subscribeSubscribe
price-trendAsk Us
Padagis Starts Life Post-Perrigo With Eucrisa Challenge

Padagis Starts Life Post-Perrigo With Eucrisa Challenge
David Wallace PHARMAINTELLIGENCE
12 Oct 2021
Share Share
Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®

Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®
PRNEWSWIRE
28 Sep 2021
Share Share
Pfizer Europe Generic Staquis(Crisaborole) Receives Approval In Europe

Pfizer Europe Generic Staquis(Crisaborole) Receives Approval In Europe
EMA
22 Apr 2020
Share Share
U.S. FDA Approves Supplemental sNDA for Expanded Indication of EUCRISA®

U.S. FDA Approves Supplemental sNDA for Expanded Indication of EUCRISA®
BUSINESSWIRE
24 Mar 2020
Share Share
Givlaari, Nubeqa among Jan CHMP decisions

Givlaari, Nubeqa among Jan CHMP decisions
Anna Smith PHARMATIMES
03 Feb 2020
Share Share
Hey, big spender: Pharma`s $6.6B TV ad outlay outranks most other industries

Hey, big spender: Pharma`s $6.6B TV ad outlay outranks most other industries
Beth Snyder Bulik FIERCE PHARMA
16 May 2019
Share Share
Novartis orchestrates $1.1B deal for a MorphoSys/Galapagos eczema drug

Novartis orchestrates $1.1B deal for a MorphoSys/Galapagos eczema drug
Amber Tong ENDPTS
20 Jul 2018
Share Share
Growth of Sanofi-Regeneron`s Dupixent in Atopic Dermatitis First Plateau

Growth of Sanofi-Regeneron`s Dupixent in Atopic Dermatitis First Plateau
PR NEWSWIRE
02 Feb 2018
Share Share
Pfizer rolls Eucrisa campaign as Dupixent heats up eczema market

Pfizer rolls Eucrisa campaign as Dupixent heats up eczema market
Beth S. Bulik FIERCE PHARMA
23 Aug 2017
Share Share